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Abstract
Purpose
This study aimed to assess the effectiveness of a care management intervention in improv-
ing self-management behavior in multimorbid patients with type 2 diabetes; care was deliv-
ered by medical assistants in the context of a primary care network (PCN) in Germany.
Methods
This study is an 18-month, multi-center, two-armed, open-label, patient-randomized paral-
lel-group superiority trial (ISRCTN 83908315). The intervention group received the care
management intervention in addition to the usual care. The control group received usual
care only. The primary outcome was the change in self-care behavior at month 9 compared
to baseline. The self-care behavior was measured with the German version of the Summary
of Diabetes Self-Care Activities Measure (SDSCA-G). A multilevel regression analysis was
applied.
Results
We assigned 495 patients to intervention (n = 252) and control (n = 243). At baseline, the
mean age was 68 ±11 years, 47.8% of the patients were female and the mean HbA1c was
7.1±1.2%. The primary analysis showed no statistically significant effect, but a positive trend
was observed (p = 0.206; 95%-CI = -0.084; 0.384). The descriptive analysis revealed a sig-
nificantly increased sum score of the SDSCA-G in the intervention group over time (P =
0.012) but not in the control group (p = 0.1973).
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Conclusion
The sum score for self-care behavior markedly improved in the intervention group over time.
However, the results of our primary analysis showed no statistically significant effect.
Possible reasons are the high baseline performance in our sample and the low interven-
tion fidelity. The implementation of this care management intervention in PCNs has the
potential to improve self-care behavior of multimorbid patients with type 2 diabetes.
Introduction
Chronic illness care often includes day-to-day self-care responsibilities for patients [1]. This is
especially true for diabetes. Diabetes self-care comprises a broad range of tasks such as self-
monitoring of blood glucose, being physically active or controlling one’s feet on a regular basis
[2]. Collaborative relationships with health care providers can help patients in handling and
managing these self-care tasks [3]. Primary care can play a crucial role in supporting patients’
self-care as part of comprehensive chronic care management [4].
In Germany, a primary care-based disease management program (DMP) for type 2 diabetes
was rolled out nationwide in 2002 [5]. This program comprises (among other elements) evi-
dence-based clinical guidelines and quarterly visits to a primary care provider, as well as eye
and foot exams on a regular basis [5, 6]. The German DMP for type 2 diabetes is free for
patients with statutory or private health insurance. By 2015, about 4 million patients with type
2 diabetes were enrolled [7]. It is estimated that 5.8 million people with type 2 diabetes live in
Germany [8].
However, dealing with co-morbidity in this German DMP is an enormous challenge, espe-
cially for those patients with type 2 diabetes, and nearly 90% of enrolled patients suffer from
one or more co-occurring medical condition [9]. Co-morbidities are not unique to Germany,
and primary care often has to face difficult challenges in caring for patients with multiple
chronic conditions [10, 11]. There is an increasing prevalence of multiple, co-occurring condi-
tions, especially for patients with severe diseases like diabetes mellitus [12, 13], which strongly
influences the delivery of care [14, 15]. Comorbidity is demanding for both healthcare systems
and patients; it demands complex clinical management and increasing health care costs [16–
18], as well as impaired health-related quality of life (HRQoL).
Based on concepts for the re-organization of chronic care [19, 20], care management inter-
ventions have been developed that focus on patients with multiple chronic conditions. Care
management has been defined as a set of interventions (e.g., comprehensive assessment of
patients’ medical and nonmedical needs, monitoring of individualized, evidence-based care
plans) [21] designed to assist patients in managing medical conditions and related psychoso-
cial problems more effectively [22–24].
In Germany, the implementation of these concepts in office-based primary care practices
(PCP) has been evaluated with promising results for patients with osteoarthritis [25], depres-
sion [26], chronic heart failure [27], and multi-morbidities [28]. Nevertheless, in small primary
care settings (solo practices or 2-person partnerships) resources are often limited and extensive
collaborative models, like care management, may be difficult to implement [28].
Primary care network (PCN) based approaches might ameliorate these challenges. PCNs
can facilitate the sharing of resources and reduce the organizational workload of practices [29].
In Germany, PCNs are a newer model of primary care that focuses on improved access to care
and the use of multidisciplinary teams for patients with chronic disease. PCNs consists of
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primary care physicians (PCP) and other providers working together to improve patient care
[30]. In Germany, the number of PCNs has doubled from 200 to 400 in the last decade. The
result is 30,000 physicians in PCNs, which in turn provides a strong foundation for popula-
tion-based approaches [31, 32]. PCNs have also been successfully implemented in Canada and
the US in recent years [33–35].
The primary objective in this study is to assess the effectiveness of a PCN based, IT-sup-
ported care management intervention with integrated telephone monitoring for the improve-
ment of self-care behavior among patients with type 2 diabetes mellitus and multimorbidity.
We hypothesize that this intervention will strengthen the self-care of multimorbid patients
with type 2 diabetes. We chose patients with multimorbidities because the potential for
improvements could be higher and the impact of structured care may be stronger compared to
patients without multimorbidities.
Research design and methods
This study (01/02/2014 to 31/07/2015) was designed as an 18-month, multi-center, two-
armed, open-label, parallel-group superiority, randomized controlled trial (RCT). All partici-
pants were enrolled in the German DMP for patients with type 2 diabetes. The study office was
located at the Department of General Practice and Health Services Research Heidelberg, which
was responsible for coordination, data management, randomization, and monitoring. The
intervention coordinating office was located at the ‘Genossenschaft Gesundheitsprojekt
Mannheim’ (GGM) and was responsible for data entry, validation, and administration. The
study was approved by the ethics committee of the Medical Faculty, Heidelberg University (S-
590/2013). The research protocol has been published elsewhere [36]. No changes to methods
or outcomes were made after trial commencement.
Study center
The PCN is one of three in Mannheim, a city with approximately 305,000 inhabitants in the
southwestern part of Germany. For participation in this study and to serve as a study center,
PCN physicians had to meet the following criteria: (1) Specialized in general practice, internal
medicine, or practical physician (2) working as a primary care physician according to German
regulations and (3) being part of the PCP network GGM. Participating practices remained
clinically and financially independent, but shared a number of facilities. Both single-handed
and group practices were eligible to participate. PCPs who did not fulfill the inclusion criteria
were excluded. All PCPs within the network were invited by the GGM management via an
official letter to participate in the study. All PCPs in this study gave their written consent for
participation.
Participants
Patients older than 18-years old who met all of the following inclusion criteria were eligible to
participate in the study: (1) officially diagnosed with type 2 diabetes mellitus (ICD 10:
E11-E14), (2) enrolled in the DMP Diabetes mellitus type 2 (DMP Diabetes), and (3) diag-
nosed with at least two other severe chronic comorbidities according to the definition outlined
in § 62 SGB V. These chronic comorbidities include, but are not limited to, atherosclerosis
(ICD 10: I70), chronic coronary heart disease (ICD 10: I25), chronic obstructive lung disease
(ICD 10: J44), asthma (ICD 10: J45), cerebrovascular diseases (ICD 10: I60-I69), depression
(ICD 10: F32-F33), heart failure (ICD 10: I50), Parkinson’s (ICD 10: G20), and/or chronic
pain (ICD 10: R52). Additionally, written informed consent was a prerequisite for participa-
tion in the study.
Care management in multimorbid patients with type 2 diabetes
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Patients who did not fulfill the inclusion criteria were excluded. In addition, the following
exclusion criteria for patients were applied: Severe acute psychiatric disorders, e.g., schizophre-
nia, schizotypal and delusional disorders (ICD 10:F20-F29); dementia (ICD 10:F00-F03); men-
tal and behavioral disorders due to psychoactive substance use (ICD 10:F11-F16; F18; F19);
malignant neoplasms (ICD 10:C00-C97), and/or current chemotherapy or radiotherapy; trans-
planted organ and tissue status (ICD 10:Z94); care involving dialysis (ICD 10:Z49); insur-
mountable language or communication problems; emergency cases.
Recruitment
The recruitment of patients took place between 01/02/2014 and 31/10/2014 (T0). For the
recruitment of patients, PCPs received a list with inclusion and exclusion criteria along with a
screening list and a list of random numbers. PCPs were asked to create a list of all potentially
eligible patients registered in their practice software which were enrolled in the DMP Diabetes;
these patients were then registered in their practice software in 2013. From this list, PCPs
selected patients according to the sequence indicated by the random numbers (provided by
the study office). The randomly selected patients were checked for inclusion and exclusion cri-
teria. Eligible patients were contacted and asked about their interest in participating in the
study by their PCP physician. The procedure was repeated until a total of 20 patients per PCP
were recruited. The number of patients screened and asked to participate was documented by
the PCP physician and reported to the study office.
Data collection
Patients were invited by the recruiting physician to fill out a pseudonymized paper-based ques-
tionnaire (self-administered by patients). This questionnaire captured the patient reported
outcomes (e.g., German Version of the Summary of Diabetes Self-Care Activities Measure
[29], socio-demographic aspects, and questions about utilization of health care within the last
9 months. Additionally, PCPs documented data from patients’ charts in a pseudonymized
paper-based questionnaire (clinician administered; including inclusion/exclusion criteria,
diagnoses, medication(s), hospitalizations, and hypoglycemia before recruitment) and assessed
the clinical status of the patient (e.g., blood pressure, blood glucose, latest HbA1c value). The
patient questionnaire and physician-reported chart-review were performed at baseline (T0)
and after 9 months (01/11/2014 to 31/07/2015) (T1). Longer time frames for baseline (T0) and
follow up (T1) were not feasible because of the limited length of the study. Participants were
not provided with feedback following data collection points.
Randomization
After obtaining written informed consent, patients were randomized individually at the study
office. Patients were randomly allocated by means of a randomization list, created by the trial
statistician, to care management (intervention group) or usual care (control group) at the indi-
vidual level at a ratio of 1:1. Then, patients were stratified by (1) type of medical treatment
(insulin vs. oral medication or no medication) of their index disease (type 2 diabetes) and (2)
study center (PCP) using block randomization with varying block lengths (4-4-2 scheme). The
randomization was performed at the study office by a clinical monitor, who acted as sole ran-
domization authority, within the used study-specific software. This person was not involved in
the care of the trial patients or analysis of data. The clinical monitor allocated participants who
had completed the self-administered and clinician administered questionnaire on a weekly
basis to intervention or control groups using the randomization list that was provided by the
Institute of Medical Biometry and Informatics (University Hospital Heidelberg). Therefore,
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the clinical monitor checked within the study-specific software if the written informed consent
was available, inclusion criteria were fulfilled, and type of medical treatment before randomi-
zation. Allocation to intervention or control group were recorded in the software and patients
allocated to intervention group were visible to the net care manager (NCM) within the soft-
ware. Randomization was done at the patient level, so physicians provided care for patients in
the intervention as well as control group. Blinding of physicians, medical assistants (MAs),
and patients was not possible due to the nature of the intervention. All study results are
reported according to CONSORT guidelines [42]. A flow diagram, as recommended in CON-
SORT is provided as Fig 1.
Intervention design
Intervention conditions. This intervention was a care management program aimed at
improving diabetes self-care behavior among patients with type 2 diabetes and multiple
comorbidities. The development of the multifaceted intervention was based on a 12-month
pilot study (GEDIMA), focus groups with PCP physicians and specialist care providers, and
Fig 1. CONSORT flowchart.
https://doi.org/10.1371/journal.pone.0214056.g001
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the active engagement of representatives of local patient self-help groups in formulating assess-
ment contents and identifying community resources [36].
Different to other care management interventions often implemented on practice or
insurance levels, this intervention was embedded in a PCN. This means that the care man-
ager, in this conceptual design called net-care manager (NCM), is employed by the PCP net-
work and responsible for the care management of patients from different PCPs within the
network. To ensure the continuity of care and the collaboration between involved health
professionals, a medical assistant (MA) in each PCP worked as a link between the NCM and
the responsible physician. This concept of shared resources is especially beneficial for
smaller practices without their own resources for implementing care management
approaches (Fig 2). Also, it facilitates shared learning and coordinated standardization of
healthcare delivery across practices.
The care management intervention is an add-on to treatment as usual within the DMP for
patients with type 2 diabetes and consists for those patients in the intervention group of an
individualized IT-based assessment (e.g., health care and social aspects, for details see Bozorg-
mehr et al. 2014) [36], including home visits and telephone-monitoring on a regular basis,
both provided by the NCM. Regarding the assessment, the NCM visits patients in the interven-
tion group three times at home within the first weeks after entry to the study and after 6
months (Fig 3). The results of the assessment were reported to the responsible physician via
the MA in each practice.
Fig 2. PCN-based care management.
https://doi.org/10.1371/journal.pone.0214056.g002
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The objective of the telephone-monitoring was to detect acute clinical needs and to provide
support related to self-care goals and healthcare related issues (e.g., medical or social prob-
lems). The monitoring was based on a structured list of questions, which was developed on the
basis of experiences in prior projects of this PCP network. Additionally, to this structured
monitoring, NCMs could support patients via telephone to locate additional services within
the health system or the broader community according to patients’ individual preferences and
needs. In total, 24 telephone-monitoring sessions were planned (every 2 weeks for a period of
6 months, once a month throughout the rest of the intervention period for patients in the
intervention group) (36). No additional expenses were incurred for patients in the intervention
Fig 3. Timeline and care provided in both groups.
https://doi.org/10.1371/journal.pone.0214056.g003
Care management in multimorbid patients with type 2 diabetes
PLOS ONE | https://doi.org/10.1371/journal.pone.0214056 June 12, 2019 7 / 18
group. Medical assistants providing the above described elements of the intervention to study
participants had to participate in a group-based training comprising 32 hours before the inter-
vention start.
Control conditions. Patients allocated to the control group received treatment as usual
within the scope of the German Disease Management Program for Type 2 Diabetes mellitus.
The German DMP for Type 2 Diabetes mellitus comprises (among other elements) evidence-
based clinical guidelines, quarterly visits in primary care as well as eye and foot exams on a reg-
ular basis [5, 6].
Primary and secondary outcomes
In this study, patient-level outcomes are of interest. In particular, the described intervention
was aimed at improving self-care as a multidimensional construct consisting of the following
five dimensions: diet, exercise, self-monitoring of blood glucose (SMBG) and foot care. This
primary outcome was measured with the German version of the Summary of Diabetes Self-
Care Activities Measure (SDSCA-G). This 11-item questionnaire has been shown to be a reli-
able and valid tool for assessing self-management in adults with type 2 diabetes in Germany
[29]. The English version of the SDSCA is a widely used, valid and reliable tool for capturing
self-care behavior [2, 37]. The SDSCA-G sum score was calculated as the mean of the first 10
items (not including the eleventh item measuring smoking behavior). The primary outcome
for this study was the change in self-care behavior at month 9 compared to baseline.
As secondary outcomes, the mean change in each of the five dimensions of the SDSCA-G,
the difference over time for the single SDSCA-G items and the HbA1c, the prevalence of
(severe) hypoglycemia at T0 and T1 as well as the equity/efficacy ratio among the lowest vs.
highest socioeconomic patient subgroups for the SDSCA-G score and HbA1c were considered.
Sample size calculation
The sample size was calculated based on the expected difference between the two treatment
groups in mean change in the SDSCA-G score from baseline (T0) compared to 9 months after
baseline (T1). Based on data from published studies, which used the revised SDSCA as out-
come measure [38–40], we estimated a mean change of 0.5 days (standard deviation 2.0) in the
overall SDSCA-G score (calculated as the sum of days of items 1–10 divided by 10) per patient
in 9 months as minimal clinically relevant change.
Based on these estimates, a total of 506 patients (253 per arm) would be required to detect
an effect size (Cohen’s d) of 0.25 between-groups (intervention vs. control (50% relative
increase in self-care) with a power of 80% applying a two-sided t-test for two independent
samples at a significance level of 5%. It was assumed that analyzing the data using a linear
mixed model including the fixed factor type of medical treatment, the fixed covariate baseline
SDSCA-G, and the random factor NCM would lead to less unexplained variance and thus to
an additionally increased power as compared to an analysis via two-sided t-test. Assuming a
drop-out rate of 15% over the period of 9 months, the overall required sample size amounts to
a total of 582 participants (291 per arm). No treatment by strata interaction was assumed in
the sample size calculation, which was performed using ADDPLAN v6.0. (ICON, Leopards-
town, Ireland). We did not conduct interim analyses and had no stopping guidelines.
Statistical methods
The primary outcome was the change in SDSCA-G score from baseline (T0) to 9 months after
baseline (T1), i.e., the difference SDSCA-G T1 –T0. The study objective was statistically formu-
lated as a test of the null hypothesis H0: μ1 = μ2 (the mean difference SDSCA-G T1–T0 is
Care management in multimorbid patients with type 2 diabetes
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equal in the two groups) against the alternative hypothesis H1: μ1 6¼ μ2 (the mean difference
SDSCA-G T1–T0 is different in the two groups). The null hypothesis was tested at the two-
sided significance level of α = 0.05. The primary analysis was carried out according to the
intention-to-treat principle, i.e., all randomized subjects were included.
The difference SDSCA-G T1–T0 was described by treatment arm and in total. The number
of cases, mean, standard deviation, median, interquartile range (IQR), minimum, and maximum
were determined. Due to the hierarchical structure of the data, a multilevel analysis was per-
formed with patients at level one and NCMs at level two. The primary (linear mixed) model
with the SDSCA-G score difference T1 –T0 as the response variable include treatment group,
type of medical treatment, and baseline SDSCA-G (T0) as fixed factors and NCM as random fac-
tor (i.e., NCM as random intercept) to account for the two-level data structure (patients nested
in NCMs). The random intercept, as well as the residuals, was assumed to be normally distrib-
uted with variance s2b and s
2
e , respectively. The results are presented as the mean between-group
difference in SDSCA-G T1–T0 with the corresponding two-sided 95% confidence interval. The
associated Cohen’s effect size d was calculated. To fit the primary model, as well as all models
described in the next sections, the restricted maximum likelihood (REML) approach was used.
Only the results from the primary analysis are to be interpreted in a confirmatory manner. Miss-
ing data in the primary outcome was addressed through the use of multiple imputation, taking
the covariates intervention group and type of medical treatment into account by application of
the fully conditional specification method [41]. This was realized using the option “FCS” of the
SAS “MI” procedure, which is implemented in SAS v9.4 (SAS Institute, Carey, NC).
To support the primary analysis some sensitivity analyses were conducted, e.g., a complete
case analysis, an analysis including an interaction term between type of medical treatment and
intervention group, and analysis taking a number of comorbidities, age, and gender into
account. Additionally, the SDSCA sum score and all subscores were assessed separately for the
intervention and control group by using the complete case multi-level model’s least square
means estimates, thus providing linear contrasts for treatment effects over time within each
group. These models were also used to calculate intra-class correlation coefficients (ICC), mea-
suring the amount of variance additionally explained by the two-level structure. As further sec-
ondary outcomes, the SDSCA items and the HbA1c difference over time (for the total patient
population and for the subgroup with a baseline HbA1c below 7.5%) were analyzed analo-
gously with two-level linear mixed models taking the respective baseline value and type of
medical treatment into account. Furthermore, the prevalence of (severe) hypoglycemia at T0
and T1 was assessed descriptively by means of absolute and relative frequencies per group
since. Also, the equity/efficacy ratio will be calculated as the ratio between the change (com-
pared to T0 at T1) in SDSCA-G ‘score’ and HbA1c (%) between the lowest vs. highest socio-
economic patient subgroups (including education, income, degree, and migrant status), where
confidence intervals for the ratios were determined using a bootstrap approach with 1,000,000
simulated datasets. Statistical analyses were carried out using SAS v9.4 (SAS Institute, Carey,
NC) and IBM SPSS Statistics for Windows, version 25 (IBM Corp., Armonk, NY., USA).
Results
No harms or unintended effects of this study have been reported within in the intervention
group or the control group.
Study enrollment and follow up
The recruitment of study patients took place in primary care practices within the GGM net-
work between February and October 2014. Overall, a total of 1,541 patients were assessed for
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eligibility. Patients were excluded (n = 531) that did not meet the inclusion criteria; 296
patients declined to participate, and 219 patients were excluded for other reasons. The remain-
ing 495 patients were randomized to intervention (n = 252) or control (n = 243). Two hundred
and twenty-seven (90.1%) patients in the intervention and 219 (90.1%) patients in the control
group remained in the trial until follow-up, leaving an arrition rate of 9.9% in both study
groups. The per protocol (PP) set comprised 119 patients in the intervention and 219 patients
in the control group.
Characteristics of patients
In the intervention group, 47.2% were female, the mean age ± SD was 68 ± 11 years, and the
mean Body Mass Index (BMI) was 31.5±6.7 kg/m2. The diabetes duration was 14.1 ± 9.5 years,
and the HbA1c was 7.1 ± 1.2% (148.1 ± 47.6 mg/dl) on average. Of all patients in the interven-
tion group, 33.7% received treatment with insulin. On average, every patient had 3.8 additional
conditions (Table 1).
In the control group, 48.5% were female, the mean age ± SD was 68 ± 11 years, and the mean
BMI was 31.6±6.0 kg/m2. The diabetes duration was 15.1 ± 12.1 years, and the HbA1c was
7.3 ± 1.2% (151.8 ± 50.1 mg/dl) on average. Of all patients in the intervention group, 33.3%
received treatment with insulin. On average, every patient had 3.7 additional conditions (Table 1).
Characteristics of physicians, medical assistants, and net case manager
The mean age ± SD of participating physicians (n = 32; 45.2% female) was 54.6 ± 9.3 years old.
Their average work experience ± SD was 25.9 ± 8.8 years. Of all participating practices, 66.7%
were single-handed. Regarding MAs (N = 23; 100.0% female) and NCMs (N = 11; 100.0%
Table 1. Patient characteristics—comparison between groups at baseline.
Intervention N Control N
Number 252 243
Age years (SD) 68.40 (11.33) 249 68.31 (10.80) 238
Female 47.22% 119 48.56% 118
Married / cohabited 58.73% 148 53.09% 129
Up to 9 years in school 30.16% 76 26.75% 65
Professional education� 66.67% 168 67.07% 163
Diabetes duration in years (SD) 14.13 (9.50) 187 15.06 (12.07) 173
Treatment with Insulin 33.7% 85 33.3% 81
Enrolled in an additional DMP$ 23.8% 60 28.0% 68
Number of Comorbidities 3.79 (1.16) 252 3.74 (1.22) 243
Mobility restrictions 18.7% 47 17.3% 42
Hospital stays per patients# 0.19 (0.51) 252 0.23 (0.61) 243
Systolic blood pressure (mmHg) 135.45 (14.65) 252 133.88 (14.25) 243
Diastolic blood pressure (mmHg) 80.27 (8.84) 252 79.63 (8.59) 243
Blood glucose (mg/dl) 148.11 (47.56) 252 151.76 (50.13) 243
Blood glucose (HbA1C) 7.13 (1.23) 252 7.25 (1.19) 243
BMI calculated 31.52 (6.73) 252 31.62 (5.97) 243
�minimum vocational training
$Asthma, CHD, COPD
#last 9 month
https://doi.org/10.1371/journal.pone.0214056.t001
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female) their mean age ± SD was 43.5 ± 12.1 years and 42.7 ± 9.5 years respectively. The mean
work experience ± SD of MAs was 21.4 ± 12.4 years and for NCMs 22.3 ± 9.8 years (Table 2).
Descriptive analysis
At baseline (T0) valid sum scores for 368 patients were available (intervention (I) = 186; con-
trol (C) = 182) and the mean SDSCA sum score in the intervention group was 3.31 +/-1.11 vs.
3.50 +/-1.23 in the control group. After 9 months, valid sum scores for 345 patients were avail-
able (I = 181; C = 164) and the mean SDSCA sum score sample in the intervention group was
3.63 +/-1.22 vs. 3.58 +/-1.22 in the control group. More detailed information is available in the
appendix (S1 Appendix, Table B).
The analysis of differences over time within treatment groups has shown significantly
increased values from T0 to T1 within the intervention group for the SDSCA sum score
(p = 0.012). Within the control group, none of the scores have changed significantly (Table 3).
Primary outcome
The primary analysis showed an intervention effect of 0.14 (intervention–control) for the dif-
ference in SDSCA sum score between T1 and T0, which was, however, not statistically signifi-
cant (p = 0.2063, 95%-CI = [-0.0838; 0.3844], Cohen’s d = 0.1597). Sensitivity analyses yielded
results that were in line with this finding (Table 4). The ICC amounted to 2.3%, thus, a small,
but nonetheless existent dependency between patients assigned to the same NCM was
observed.
Secondary outcomes
The analysis of secondary outcomes has shown no significant change for the sub-score diet
(p = 0.1385, 95%-CI = [-0.0591; 0.4229], Cohen’s d = 0.1444), exercise (p = 0.7137, 95%-CI =
[-0.2658; 0.3878], Cohen’s d = 0.0343), blood glucose testing (p = 0.2227, 95%-CI = [-0.8750;
0.2057], Cohen’s d = -0.1789), and foot care (p = 0.8472, 95%-CI = [-0.3482; 0.4239], Cohen’s
d = 0.0185) (Table 5). However, the analysis of the difference over time for the single SDSCA-
Table 2. Characteristics of physicians, medical assistants, and net case manager (NCM).
Physicians N MA N NCM N
Age years (mean, SD) 54.6 (9.3) 32 43.5 (12.1) 23 42.7 (9.51) 11
Female (percent) 45.2% 14 100.0% 23 100.0% 11
Years of work experience (mean, SD) 25.9 (8.8) 30 21.4 (12.4) 23 22.3 (9.8) 11
https://doi.org/10.1371/journal.pone.0214056.t002
Table 3. Description of SDSCA scores within the intervention and control group alongside p-values for differences in scores over time.
SDSCA-G Intervention Control group
T0 T1 P�� P��
N Mean SD N Mean SD N Mean SD N Mean SD
sum 186 3.31 1.11 181 3.63 1.22 0.012 182 3.50 1.23 164 3.58 1.22 0.197
diet 208 4.30 1.58 199 4.54 1.50 0.180 201 4.38 1.76 186 4.40 1.72 0.959
exercise 231 3.13 1.84 209 3.12 1.83 0.876 220 3.01 1.85 194 3.10 2.01 0.731
BST� 78 5.48 2.28 73 5.58 2.01 0.781 75 5.45 2.26 68 5.93 1.90 0.051
foot care 222 2.47 2.19 211 2.85 2.28 0.207 223 3.06 2.25 195 3.15 2.46 0.322
�blood sugar test
��p-value for testing whether least square means are equal to 0, based on linear mixed model with repeated measurements
https://doi.org/10.1371/journal.pone.0214056.t003
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G items (S1 Appendix, Table C) and the HbA1c (S1 Appendix, Table D), the prevalence of
(severe) hypoglycemia at T0 and T1 (S1 Appendix, Table E) as well as the analysis of equity/
efficacy ratio (S1 Appendix, Table F) haven’t shown noteworthy results.
Intervention fidelity
Overall, the fidelity of the intervention was low. Only 119 patients got the intervention as
intended (per protocol; 2 home visits and 10 telephone-monitoring calls). Regarding tele-
phone-monitoring, only 6 (2.6%) patients received all planned 15 calls, whereas 1 patient
(0.4%) never received even one call. The majority of patients (83.3%) received between 8 and
14 calls within the intervention period (T0 to T1). Additionally, 190 patients (83.7%) got 2
home visits until T1 as proposed.
Differences between the intended and the implemented intervention also exist for recruit-
ing and the enrollment of patients to NCMs. Concerning recruiting, 16 physicians (47.1%)
reached the recruitment goal of 20 patients. More than 10 patients were recruited by 8 physi-
cians (23.5%). In additon, the number of patients enrolled to each NCM in the intervention
group varied between 13 patients per NCM and 31 patients per NCM.
Discussion
This study aimed to assess the effectiveness of a PCN based, IT-supported care management
intervention with integrated telephone monitoring for the improvement of self-care behavior
among patients with type 2 diabetes mellitus and multimorbidity. The results of our primary
analysis showed no statistically significant effect. The sum score for self-care behavior
increased significantly in the intervention group over time, but not in the control group. Addi-
tionally, significant changes between T0 and T1 were observed in the intervention group for
the subscores on healthy diet and foot care.
Table 4. Primary outcome.
Model Estimate 95%-CI Cohen’s d p-value
Primary model (adjusted for multilevel structure and covariates, multiple imputation on score level, ITT) 0.1503 [-0.0838;
0.3844]
0.1597 0.2063
Sensitivity analysis of primary model (adjusted for multilevel structure and covariates, no imputation, ITT) 0.1151 [-0.0927;
0.3229]
0.1223 0.2764
Sensitivity analysis of primary model (adjusted for multilevel structure covariates, and interaction between type of
medical treatment and intervention group, no imputation, ITT)
0.1246 [-0.0918;
0.3409]
0.1326 0.2580
Sensitivity analysis of primary model (adjusted for multilevel structure and covariates, no imputation, PP) 0.1517 [-0.1056;
0.4087]
0.1617 0.2466
Sensitivity analysis of primary model by two-sided t-test (unadjusted for multilevel structure, unadjusted for
covariates, no imputation, PP)
0.1858 [-0.0381;
0.4098]
0.2311 0.1035
https://doi.org/10.1371/journal.pone.0214056.t004
Table 5. SDSCA-G sub-scores�.
Estimate 95%-CI Cohen’s d p-value
Diet 0.1819 [-0.0591; 0.4229] 0.1444 0.1385
Exercise 0.0610 [-0.2658; 0.3878] 0.0343 0.7137
Blood glucose testing�� -0.3346 [-0.8750; 0.2057] -0.1789 0.2227
Foot care 0.0379 [-0.3482; 0.4239] 0.0185 0.8472
�ITT analysis (adjusted for multilevel structure and covariates)
��Insulin patients only
https://doi.org/10.1371/journal.pone.0214056.t005
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Previous studies have often either focused on strengthening self-management or the imple-
mentation of care management interventions. Whereas self-management education and train-
ing are effective [43–45], most care management programs in the US for type 2 diabetes are
carved-out, accomplish limited effects on metabolic outcomes, and have indefinite effects on
relevant patient outcomes such as health-related quality of life [46]. More recently, the imple-
mentation of care management tools like home visits and telephone-based intervention have
shown promising results in improving self-care in patients with type 2 diabetes [23, 47–49].
However, none of those interventions addressed multimorbid patients and implementation
in primary care remains scarce [36]. The lack of resources in primary care practices to imple-
ment care management programs might be a reason for this lack. Especially in chronic care,
comprehensive and interprofessional approaches are urgently needed to address diabetes and
comorbidities. PCNs could offer the necessary infrastructure and previous research has shown
that diabetes care in PCNs is associated with more frequent guideline-recommended screening
and a lower rate of admissions to hospitals or visits to emergency departments [30].
Nevertheless, strengthening self-care in patients with comorbidities is still a challenge. As
shown by the study of Bos-Touwen et al. (2015), the burden of disease (e.g., regarding comor-
bidities) and disease duration are associated with poor activation for self-management [50].
Moreover, compliance or adherence to self-care activities are often low, particularly regarding
long-term changes. Multiple demographic, socio-economic and social support related aspects
play a critical role in self-management and have to be considered in facilitating self-care activi-
ties in patients with diabetes [3].
Previous research indicates that, in particular, patients with suboptimal or poor glycemic
control receive a greater benefit from self-management programs [51]. On the other hand,
controlling blood sugar is well implemented in the German DMP for Type 2 Diabetes [52].
Accordingly, in our study population, the HbA1C was modest for both groups. This could be
one reason why no larger effects were observed in our study. Another reason could be that the
quality of care in diabetes patients is already high. Besides the impact of the German DMP
[52–54], for example, the study of Nouwens et al. (2012) has shown that the presence of diabe-
tes is associated with better preventative treatment of cardiovascular risk factors [55].
Additionally, the implementation of complex interventions in healthcare practice is often
challenging [56], resulting in suboptimal delivery of the planned interventions. Low interven-
tion fidelity is one of the potential explanations for the lack of effect in this trial. This is particu-
larly relevant for intervention components, which have been shown to be effective in previous
research. Examples are medical assistant-based telephone monitoring or the implementation
of the intervention in primary care practices [26, 28].
Regarding future development in this area, there are important lessons we have learned
with this study. First, PCN-based care management interventions have the potential to
improve self-care behavior among multimorbid patients with type 2 diabetes. To reach this
aim, future implementations should focus on intervention fidelity and the improvement of
intervention elements.
In particular, a stronger definition of the concept for home visits and the telephone-moni-
toring seems to be appropriate. Although there were guidelines in our study, the individual
implementation was strongly dependent on the specific NCM. The integration of motivational
interviewing strategies could be helpful to improve both the focus and the results of the NCM
intervention. As shown by Masterson et al. (2016) in patients with chronic heart failure, moti-
vational interviewing used during home visits and follow up calls can lead to significant and
clinically meaningful improvements in self-care maintenance [57].
Too, it is important to improve the process of communication between the NCM, the medi-
cal assistant, and the treating physician (see Fig 1). In our study, the treating physicians were
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not always well informed about the results of the home visits and telephone calls done by the
NCM. This is problematic because the role of physicians in promoting self-care is vital. In par-
ticular, trust seems to be important. The study of Bonds et al. (2004) indicates that higher
patient trust in physicians is associated with reduced patient difficulty in completing disease-
specific tasks [58].
Finally, this study was focused on the individual patient. Further development of this PCN-
based care management approach could involve the social network of patients to a greater
extent. Since primary care physicians often provide care to multiple family members, they are
ideally positioned to expand this intervention [56] to include patient support networks. Addi-
tionally, community and social support networks operating in patients’ lives should be more
engaged [59].
Strength and limitations
To the best of our knowledge, this study is the largest RCT in primary care to evaluate a care-
management intervention aimed at improving self-care. The implementation in a PCN and
the focus of multimorbid patients with type 2 diabetes are also highly innovative. The collec-
tion of relevant data for the analysis was done with well-established measures to generate
highly valid data. In addition, biomedical outcomes such as laboratory measures and chronic
conditions used in this study were determined by healthcare professionals, rather than being
self-reported by patients. The multi-level approach used in this study is seen as relevant in
health services research due to the hierarchical structure of the patients’ data clustered in PCP-
teams [60]. However, the primary analysis showed no statistically significant effect and the
recruitment target was not achieved. Instead of 600 patients, we were able to recruit 495
patients. Recruitment of patients was not stopped actively. However, participating study cen-
ters were not able to enroll additional eligible patients. Of these 495 patients, only 448 com-
pleted follow-up, which was below the calculated net sample size of 506 required to detect the
assumed treatment effect of d = 0.25 with a t-test; this resulted in a slight underpowering of the
study (achieved power with n = 448 patients amounts to only 75.18% under the same assump-
tions). Moreover, due to the randomization on patient level there was an increased risk of con-
tamination of intervention effects. Regarding the implementation, the intervention fidelity in
this study was moderate and we used a convenience sample of PCP-teams in only one PCN.
The motivation of the participating PCP-teams may not be comparable to PCP-teams in gen-
eral. Therefore, the generalizability of the findings is limited.
Conclusions
The results of our primary analysis showed no statistically significant effect. Otherwise, the
sum score for self-care behavior increased significantly in the intervention group over time,
but not in the control group. Possible reasons are the high baseline performance in our sample
and the low intervention fidelity. The future development of this approach should focus on a
closer definition of the intervention, improvements regarding the communication between the
NCM and the treating practice, as well as an increased engagement of the social network. Espe-
cially for smaller primary care practices, the implementation of care management in PCNs
may improve the self-care behavior of patients.
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